Navigation Links
Quest Diagnostics to Speak at the Jefferies 2011 Global Healthcare Conference
Date:6/3/2011

MADISON, N.J., June 3, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies 2011 Global Healthcare Conference in New York City. The presentation is scheduled for Monday, June 6, 2011 at 8:30 a.m. Eastern Time.

The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://www.wsw.com/webcast/jeff60/dgx/ and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available starting one hour after the conclusion of the live event and will remain available until July 6, 2011.

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.QuestDiagnostics.com.

Contacts:

Kathleen Valentine (Investors):   973-520-2900
Wendy Bost (Media):                   973-520-2800


'/>"/>
SOURCE Quest Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. New Study Questions Ability of Radiology Benefit Managers to Lower Costs
2. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
3. Quest Diagnostics Successfully Completes Acquisition of Celera
4. Quest Diagnostics Declares Quarterly Cash Dividend
5. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
6. Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger
7. Quest Diagnostics Sponsors American Cancer Societys Choose You® Movement
8. Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera
9. Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing
10. Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe
11. Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
Breaking Medicine News(10 mins):